EP783: MAGNOLIA: Phase 2 study of zanubrutinib in R/R marginal zone lymphoma

EP783: MAGNOLIA: Phase 2 study of zanubrutinib in R/R marginal zone lymphoma
 ABSTRACT   06/2021

Rating

Rate this resource

Nice to see you!

For newest details on our EHA materials in a personal video meeting, please click here!
Service